Anna Maria Bochicchio
About
Anna Maria Bochicchio is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Anna Maria Bochicchio has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Anna Maria Bochicchio's work include Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (8 papers) and Metastasis and carcinoma case studies (6 papers). Anna Maria Bochicchio is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Colorectal and Anal Carcinomas (8 papers) and Metastasis and carcinoma case studies (6 papers). Anna Maria Bochicchio collaborates with scholars based in Italy, United Kingdom and United States. Anna Maria Bochicchio's co-authors include Carmine Pinto, Gerardo Rosati, C. Aschele, Luca Boni, Stefano Cordio, Maria Emanuela Negru, Domenico Corsi, L. Cionini, Maria Chiara Tronconi and Andrea Bonetti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
In The Last Decade
Anna Maria Bochicchio
38 papers receiving 1.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anna Maria Bochicchio Italy | 14 | 997 | 594 | 332 | 181 | 118 | 41 | 1.2k | ||
| Toshihide Imaizumi Japan | 16 | 803 0.8× | 542 0.9× | 363 1.1× | 301 1.7× | 105 0.9× | 76 | 1.1k | ||
| Ido Nachmany Israel | 19 | 627 0.6× | 471 0.8× | 319 1.0× | 280 1.5× | 47 0.4× | 75 | 1.1k | ||
| Jong Lyul Lee South Korea | 19 | 883 0.9× | 781 1.3× | 230 0.7× | 182 1.0× | 31 0.3× | 134 | 1.3k | ||
| Mukta Ramadwar India | 16 | 324 0.3× | 455 0.8× | 392 1.2× | 125 0.7× | 76 0.6× | 93 | 859 | ||
| Renata Zaucha Poland | 16 | 455 0.5× | 297 0.5× | 232 0.7× | 105 0.6× | 107 0.9× | 54 | 1.1k | ||
| Ryu Kanzaki Japan | 17 | 354 0.4× | 338 0.6× | 545 1.6× | 103 0.6× | 125 1.1× | 93 | 1.1k | ||
| Dhakshina Moorthy Ganeshan United States | 17 | 305 0.3× | 306 0.5× | 222 0.7× | 154 0.9× | 56 0.5× | 32 | 824 | ||
| Chiara Alessandra Cella Italy | 14 | 413 0.4× | 217 0.4× | 150 0.5× | 182 1.0× | 118 1.0× | 44 | 683 | ||
| James M. McLoughlin United States | 16 | 287 0.3× | 290 0.5× | 231 0.7× | 104 0.6× | 55 0.5× | 41 | 705 | ||
| Lucia Calculli Italy | 18 | 874 0.9× | 749 1.3× | 327 1.0× | 364 2.0× | 67 0.6× | 72 | 1.1k |
Countries citing papers authored by Anna Maria Bochicchio
Since
Specialization
Citations
This map shows the geographic impact of Anna Maria Bochicchio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maria Bochicchio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maria Bochicchio more than expected).
Fields of papers citing papers by Anna Maria Bochicchio
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anna Maria Bochicchio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maria Bochicchio. The network helps show where Anna Maria Bochicchio may publish in the future.
Co-authorship network of co-authors of Anna Maria Bochicchio
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Maria Bochicchio. A scholar is included among the top collaborators of Anna Maria Bochicchio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Maria Bochicchio. Anna Maria Bochicchio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Laurino, Simona, Sabino Russi, Alberto D’Angelo, et al.. (2024). The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review. SHILAP Revista de lepidopterología. 12(3). 47–47.
2.
Sforza, Vincenzo, Erika Martinelli, Claudia Cardone, et al.. (2017). Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme. ESMO Open. 2(4). e000229–e000229.
3.
Pinto, Carmine, M. Di Bisceglie, Francesca Di Fabio, et al.. (2016). Phase II open-label single-arm study of pre-operative panitumumab and external pelvic radiotherapy (RTE) in locally advanced rectal cancer (LARC) patients (pts) (RaP/STAR-03 Study). Annals of Oncology. 27. iv41–iv41.
4.
Bajetta, Emilio, Irene Floriani, Maria Di Bartolomeo, et al.. (2012). Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.. Journal of Clinical Oncology. 30(18_suppl). LBA4001–LBA4001.
5.
Bochicchio, Anna Maria, Alfredo Tartarone, Giuseppe La Torre, et al.. (2012). Anal Metastasis from Breast Cancer: A Case Report and Review of the Literature. Future Oncology. 8(3). 333–336.
6.
Aschele, C., L. Cionini, Sara Lonardi, et al.. (2011). Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial. Journal of Clinical Oncology. 29(20). 2773–2780.
7.
Pinto, Carmine, Francesca Di Fabio, Evaristo Maiello, et al.. (2011). Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study). Annals of Oncology. 22(11). 2424–2430.
8.
Facchini, Gaetano, Michele Caraglia, Alessandro Morabito, et al.. (2010). Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial. Cancer Biology & Therapy. 10(6). 543–548.
9.
Fabio, Francesco Di, Carmine Pinto, Evaristo Maiello, et al.. (2009). 6045 Safety analysis of starpan (star-02) study with panitumumab, 5-fluorouracil, oxaliplatin and concurrent radiotherapy in locally advanced rectal cancer. European Journal of Cancer Supplements. 7(2). 335–335.
10.
Bartolomeo, Maria Di, Roberto Buzzoni, Luigi Mariani, et al.. (2006). Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric Adenocarcinoma. Oncology. 71(5-6). 341–346.
11.
Tartarone, Alfredo, Gianpiero Romano, Rocco Galasso, et al.. (2003). Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data. Bone Marrow Transplantation. 31(7). 525–530.
12.
Bochicchio, Anna Maria, et al.. (2001). Electromagnetic Interference on a Telecommunication Cable from a Railway Line: Comparison between Calculations and Measurements. 1–6.
13.
Bajetta, Emilio, Maria Di Bartolomeo, Carlo Carnaghi, et al.. (1998). FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study. British Journal of Cancer. 77(7). 1149–1154.
14.
Leo, Angelo Di, Emilio Bajetta, Roberto Buzzoni, et al.. (1995). Epirubicin Plus Medroxyprogesterone as Second-Line Treatment of Advanced Prostatic Cancer. American Journal of Clinical Oncology. 18(3). 239–244.
15.
Bartolomeo, Maria Di, Emilio Bajetta, Filippo de Braud, et al.. (1995). Phase II Study of the Etoposide, Leucovorin and Fluorouracil Combination for Patients with Advanced Gastric Cancer Unsuitable for Aggressive Chemotherapy. Oncology. 52(1). 41–44.
16.
Bartolomeo, Maria Di, Emilio Bajetta, Anna Maria Bochicchio, et al.. (1995). A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group. Annals of Oncology. 6(1). 77–79.
17.
Bajetta, Emilio, Nicoletta Zilembo, Maria Di Bartolomeo, et al.. (1993). Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology Group. Cancer. 72(10). 3099–3105.
18.
Bajetta, Emilio, et al.. (1993). RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN THE TREATMENT OF ANEMIA ASSOCIATED WITH SOLID TUMORS WITH OR WITHOUT BONE-MARROW INFILTRATION. International Journal of Oncology. 3(6). 1121–6.
19.
Colleoni, Marco, Roberto Buzzoni, Emilio Bajetta, et al.. (1993). A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma. Cancer. 72(11). 3196–3201.
20.
Colleoni, Marco, Emilio Bajetta, P. Nelli, et al.. (1993). Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: The experience of the National Cancer Institute of Milan. Annals of Oncology. 4(6). 489–493.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Toshihide Imaizumi Breakdown of academic impact, for papers by Ido Nachmany Breakdown of academic impact, for papers by Jong Lyul Lee Breakdown of academic impact, for papers by Mukta Ramadwar Breakdown of academic impact, for papers by Renata Zaucha Breakdown of academic impact, for papers by Ryu Kanzaki Breakdown of academic impact, for papers by Dhakshina Moorthy Ganeshan Breakdown of academic impact, for papers by Chiara Alessandra Cella Breakdown of academic impact, for papers by James M. McLoughlin Breakdown of academic impact, for papers by Lucia Calculli